Acupuncture for Chronic Pain-Related Insomnia: A Systematic Review and Meta-Analysis

Insomnia related to chronic pain represents one of the most challenging situations for patients and health care professionals. Chronic pain, defined as that which persists for at least three months, affects between 10% and 25% of adults and is one of the leading causes of impaired quality of life. When chronic pain is associated with insomnia, a complex vicious cycle is established: pain disrupts sleep, and lack of sleep increases pain sensitivity. In the United States, about 63% of patients with chronic pain report sleep problems and are three times more likely to develop insomnia.

This bidirectional relationship generates enormous costs for health systems, estimated at approximately 650 billion dollars annually in the United States alone. Conventional treatments with medications, although available, have important limitations because of significant side effects, including dependence, allergic reactions, dizziness, and gastrointestinal problems. Even psychological therapies such as cognitive behavioral therapy, considered first-line treatment, show limited efficacy in these complex cases.

The objective of this study was to systematically assess the efficacy of acupuncture in the treatment of insomnia associated with chronic pain. The researchers performed a systematic review with meta-analysis, searching seven electronic databases from inception through December 2018. Only randomized clinical trials comparing manual acupuncture with sham (placebo) acupuncture or conventional drug treatments were included. The meta-analysis included nine studies with 944 patients, eight of which were conducted in China and one in the United States.

The studies assessed different aspects of clinical improvement through effectiveness and cure rates, in addition to standardized instruments such as the Pittsburgh Sleep Quality Index (PSQI) and the Visual Analog Scale (VAS) for pain. The researchers also analyzed treatment safety through the recording of adverse events. The methodological quality of the studies was assessed following rigorous criteria established by the Cochrane Collaboration.

The results showed that acupuncture was significantly superior to control groups on all primary outcomes. The overall effectiveness rate showed a marked advantage for acupuncture, with an odds ratio of 8.09, indicating that patients treated with acupuncture were more than eight times more likely to show clinical improvement. The cure rate also favored acupuncture, with an odds ratio of 3.17. When analyzed specifically against medications, acupuncture maintained statistically significant superiority for both effectiveness and cure.

However, when compared with sham acupuncture, although it showed an advantage in effectiveness rate, there was no statistically significant difference in cure rate, based on only one included study. Sleep quality, measured by the PSQI, showed a mean improvement of 2.65 points favoring acupuncture, a clinically relevant difference. Pain intensity also decreased significantly, with a mean reduction of 1.44 points on the VAS. With regard to safety, there was no statistical difference in adverse events between acupuncture and control groups, and the side effects reported were mild, mainly including local pain at the needle insertion site and small hematomas.

These findings have important implications for both patients and clinicians. Acupuncture emerges as a promising therapeutic option for people who suffer from the dual burden of chronic pain and insomnia, especially those who seek alternatives to medications or who experience intolerable side effects with conventional treatments. For health care professionals, the results suggest that acupuncture can be recommended as a safe and effective treatment, offering a valuable nonpharmacological approach. Acupuncture acts through complex mechanisms that involve the central and peripheral nervous systems, promoting the release of endogenous opioid peptides for pain relief and increasing the expression of melatonin to improve sleep.

This dual action is particularly relevant in insomnia associated with chronic pain, where both problems need to be addressed simultaneously. The minimal side effects make acupuncture especially attractive for elderly patients or those with multiple medical conditions who do not tolerate medications well.

However, this study has important limitations that should be considered when interpreting the results. The relatively small number of included studies and the limited sample size may compromise the precision of the evidence. The methodological quality of the studies was deemed low in most cases, with only four studies adequately describing the randomization method, none mentioning allocation concealment, and only two reporting details on assessor blinding. The inability to blind therapists who deliver acupuncture is an inherent limitation of this type of intervention.

In addition, the clinical effectiveness criteria used do not follow internationally accepted standards, being based mainly on subjective patient assessments. The analysis of adverse events was limited, as few studies reported sufficient details on safety. The authors also identified publication bias in some results, possibly due to non-publication of negative results. Considering these limitations, the researchers recommend that future studies be conducted with greater methodological rigor, larger samples, and adherence to international standards to strengthen the evidence on the efficacy of acupuncture in this challenging condition.